Emergency haegarda C1 inhibitor
Ended Awarded
- Contract number
- 36C24826F0037
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $124,240
Award facts
- Contract value 100% obligated
- $124,239.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
CSL Behring LLC, a global biotherapeutics company specializing in plasma-derived and recombinant therapies, was awarded a delivery order valued at $124,239.92 by Veterans Integrated Service Network 8 (VISN 8) for emergency procurement of HAEGARDA C1 Inhibitor. The contract, awarded on October 22, 2025, with a completion date of November 22, 2025, utilizes firm fixed pricing and carries no set-aside designation. The award is issued under CSL Behring's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which maintains a ceiling value of $201.5 million through September 2026. Performance of this delivery order will take place at CSL Behring's facility in King of Prussia, Pennsylvania.
HAEGARDA is a specialized pharmaceutical treatment for hereditary angioedema, a rare and complex medical condition affecting veterans served by VISN 8. This delivery order supports the Department of Veterans Affairs' healthcare programs by providing critical medication through a pre-negotiated pricing structure under CSL Behring's existing Blanket Purchase Agreement for HAEGARDA, which carries a $17.5 million ceiling through September 2025. CSL Behring has consistently served as a primary supplier of specialty pharmaceuticals to the VA across multiple VISNs, leveraging its established indefinite delivery vehicles to ensure efficient procurement and timely delivery of essential medications to VA medical facilities nationwide.
Quick answers
Who was awarded contract 36C24826F0037?
36C24826F0037 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 22, 2025.
How much is contract 36C24826F0037 worth?
The government has obligated $124,240 on 36C24826F0037.
Is contract 36C24826F0037 an order under another contract?
Yes. 36C24826F0037 is a delivery order under 36F79721D0249, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24826F0037 competed?
The extent of competition for 36C24826F0037 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award